Research Information and Inventions. The entire right, title and interest in:
(a) AVEO Information and Inventions shall be owned solely by AVEO;
(b) MERCK Information and Inventions shall be owned solely by MERCK; and
(c) Joint Information and Inventions shall be owned jointly by AVEO and MERCK. AVEO shall disclose to MERCK the development, making, conception and/or reduction to practice of AVEO Information and Inventions and Joint Information and Inventions during meetings of the Committee. MERCK shall disclose to AVEO the development, making, conception and/or reduction to practice of MERCK Information and Inventions and Joint Information and Inventions during meetings of the Committee.
Research Information and Inventions. The entire right, title and interest in:
2.9.1 Company Information and Inventions shall be owned solely by Company;
2.9.2 Merck Information and Inventions shall be owned solely by Merck; and
2.9.3 Joint Information and Inventions shall be owned jointly by Company and Merck. Company shall promptly disclose to Merck in writing the development, making, conception or reduction to practice of Company Information and Inventions and Joint Information and Inventions. For the purposes of determining ownership under this Section 2.9, inventorship shall be determined in accordance with United States patent laws (regardless of where the applicable activities occurred). Subject to the licenses granted to the other party under this Agreement and the other terms and conditions of this Agreement, each Party shall have the non-exclusive right to exploit its interest in Joint Information and Inventions and Joint Patent Rights, and to grant licenses under its interest in Joint Information and Inventions and Joint Patent Rights, as it deems appropriate, without the consent of, and without accounting to, the other Party; provided, however, that for clarity, the foregoing joint ownership rights shall not be construed as granting, conveying or creating any license or other rights to the other Party’s intellectual property, unless otherwise expressly set forth in this Agreement; and further provided that, in the event that any Joint Patent Rights claim or cover a Compound or the Manufacturing process therefor, Company shall not grant any license under its interest in such Joint Patent Rights to any Third Party without Merck’s prior written consent.
Research Information and Inventions. Subject to the licenses granted pursuant to the terms of this Agreement, the entire right, title and interest in:
(a) RENOVIS Information and Inventions shall be owned solely by RENOVIS;
(b) MERCK Information and Inventions shall be owned solely by MERCK; and
(c) Joint Information and Inventions shall be owned jointly by RENOVIS and MERCK. Notwithstanding the above, any Inventions that are Improvements to RENOVIS Patent Rights or RENOVIS Technology shall be owned by RENOVIS and any Inventions that are Improvements to MERCK Patent Rights shall be owned by MERCK, subject in all cases to the licenses granted pursuant to the terms of this Agreement.
Research Information and Inventions. The entire right, title and interest in:
(a) ZNOMICS Information and Inventions shall be owned solely by ZNOMICS;
(b) MERCK Information and Inventions shall be owned solely by MERCK; and
(c) Joint Information and Inventions shall be owned jointly by ZNOMICS and MERCK. Inventorship will be determined in accordance with United States patent laws. ZNOMICS shall promptly disclose to MERCK in writing the development, making, conception or reduction to practice of ZNOMICS Information and Inventions and Joint Information and Inventions.
Research Information and Inventions. 10 2.10 Research Program Term...............................................11 2.11 Research Program Materials..........................................12 2.12 Drug Development Program............................................12
Research Information and Inventions. Research Information and Inventions developed or invented:
(a) (i) solely by employees, agents or consultants of Transcell (other than Xxxxxx Xxxxx or Xxxxxxx Xxxxxx-Xxxxx) shall be owned by Transcell; (ii) solely by employees, agents or consultants of Princeton and subject to the 1993 Princeton License Agreement shall be owned by Princeton, subject to Transcell's rights under the 1993 Princeton License Agreement; and (iii) jointly by employees, agents or consultants of Transcell (other than Xxxxxx Xxxxx or Xxxxxxx Xxxxxx- Xxxxx) and Princeton and subject to the 1993 Princeton License Agreement shall be owned jointly by Transcell and Princeton ((i), (ii) and/or (iii) individually or collectively, "Transcell Information and Inventions");
(b) solely by employees, agents or consultants of Princeton and subject to the 1997 Princeton Research Agreement shall be owned by Princeton, subject to Interneuron's rights under the 1997 Princeton Research Agreement ("Interneuron Information and Inventions"),;
(c) solely by employees, agents or consultants of Merck shall be owned solely by Merck ("Merck Information and Inventions");
(d) (i) jointly by employees, agents or consultants of Transcell (other than Xxxxxx Xxxxx or Xxxxxxx Xxxxxx-Xxxxx) and Merck shall be owned jointly by Transcell and Merck; and (ii) jointly by employees, agents or consultants of Princeton and Merck and subject to the 1993 Princeton License Agreement shall be owned jointly by Princeton and Merck with Princeton's interest in such Research Information and Inventions subject to Transcell's rights under the 1993 Princeton License Agreement ((i) and/or (ii) individually or together, "Transcell/Merck Joint Information and Inventions");
(e) jointly by employees, agents or consultants of Princeton and Merck and subject to the 1997 Princeton Research Agreement shall be owned jointly by Princeton and Merck with Princeton's interest in such Research Information and Inventions subject to Interneuron's rights under the 1997 Princeton Research Agreement ("Interneuron/Merck Joint Information and Inventions"); and
(f) jointly by employees, agents or consultants of Princeton and Transcell (other than Xxxxxx Xxxxx or Xxxxxxx Xxxxxx-Xxxxx) and subject to the 1997 Princeton Research Agreement shall be owned jointly by Princeton and Transcell with Princeton's interest in such Research Information and Inventions subject to Interneuron's rights under the 1997 Princeton Research Agreement ("Interneuron/Transcell Joint ...
Research Information and Inventions. The entire right, title and interest in:
2.7.1 Company Information and Inventions shall be owned solely by Company;
2.7.2 Merck Information and Inventions shall be owned solely by Merck;
2.7.3 Joint Information and Inventions shall be owned jointly by Company and Merck;
2.7.4 Company Background Information and Inventions shall be owned solely by Company; and
2.7.5 Merck Background Information and Inventions shall be owned solely by Merck. Company shall promptly disclose to Merck any Company Information and Inventions, and each Party shall promptly disclose to the other Party any Joint Information and Inventions, in each case, in writing promptly following the development, making, conception or reduction to practice of thereof. For the purposes of determining ownership under this Section 2.7, inventorship shall be determined in accordance with United States patent laws (regardless of where the applicable activities occurred). Subject to the licenses granted to the other party under this Agreement and the other terms and conditions of this Agreement, each Party shall have the non-exclusive right to exploit its interest in Joint Information and Inventions and Joint Patent Rights, and to grant licenses under its interest in Joint Information and Inventions and Joint Patent Rights, as it deems appropriate, without the consent of, and without accounting to, the other Party; provided, however, that for clarity, the foregoing joint ownership rights shall not be construed as granting, conveying or creating any license or other rights to the other Party’s intellectual property, unless otherwise expressly set forth in this Agreement; and further provided that, for the avoidance of doubt, in the event that any Joint Patent Rights claim or cover a Product or the manufacturing process therefor, Company shall not grant any license under its interest in such Joint Patent Rights to any Third Party without Merck’s prior written consent.
Research Information and Inventions. All information and inventions conceived or reduced to practice in the course of the Research Program:
(a) solely by employees of Isis shall be owned solely by Isis;
(b) solely by employees of Merck (or its agents or Affiliates) shall be owned solely by Merck;
(c) jointly by employees of Isis and Merck (or its Affiliates) shall be owned jointly by Isis and Merck. Isis shall promptly disclose to Merck the development, making, conception or reduction to practice of the research information and inventions referred to in subsections (a) and (c) herein.
Research Information and Inventions. All Sutro Information and Inventions, Joint Information and Inventions, Merck Information and Inventions, Pre-Existing Sutro Know-How; and any Patent Rights reciting or claiming such Information and Inventions or Know-How shall constitute “Collaboration IP”. The entire right, title and interest in:
2.11.1 Program Collaboration IP shall be owned solely by Merck; and Sutro shall assign and hereby assigns to Merck all its right, title and interest in and to any such Program Collaboration IP. With respect to the Pre-Existing Sutro Patent Rights, Sutro shall assign and hereby assigns such Patent Rights to Merck, which assignments shall be executed within [*] of the Effective Date;
2.11.2 Sutro Background Collaboration IP shall be owned solely by Sutro; and Merck shall assign and hereby assigns to Sutro all its right, title and interest in and to any such Program Collaboration IP;
Research Information and Inventions. The entire right, title and interest in:
2.7.1 Avalon Information and Inventions and the intellectual property rights therein shall be owned solely by Avalon;
2.7.2 Merck Information and Inventions and the intellectual property rights therein shall be owned solely by Merck; and
2.7.3 Joint Information and Inventions and the intellectual property rights therein shall be owned *. Notwithstanding anything to the contrary in subsections 2.7.1 through 2.7.3 and without limiting any other provision of this Agreement, all Hit Compounds, Lead Compounds, Nominated Compounds and Licensed Compounds shall be subject to the Parties’ further covenants in Section 2.12. Avalon shall promptly disclose to Merck in writing its identification of any Lead Compounds and of the development, making, conception or reduction to practice of Avalon Information and Inventions and Joint Information and Inventions.
